retatrutide ozempic vs Weight loss drug retatrutide use

This tag-team approach also means patients may experience more substantial weight loss results compared to medications that only target GLP-1 receptors

Both Eli Lilly and Novo Nordisk now also offer consumers who lack insurance coverage the option to buy Zepbound and Wegovy, respectively, on direct-to-consumer platforms at a lower cost

And that comes with some risks

Most side effects peak during dose escalation and improve at maintenance dose

This is because the medicine is still being tested

These realities show that while GLP-1s help reduce weight, they rarely address the underlying metabolic factors that drive long-term weight gain